logo

  • P-ISSN1225-0163
  • E-ISSN2288-8985
  • SCOPUS, ESCI, KCI

논문 상세

Home > 논문 상세
  • P-ISSN 1225-0163
  • E-ISSN 2288-8985

논문 상세

    Spectrofluorometric quantification of Clozapine in pharmaceutical formulations and human plasma

    Spectrofluorometric quantification of Clozapine in pharmaceutical formulations and human plasma

    분석과학 / Analytical Science and Technology, (P)1225-0163; (E)2288-8985
    2022, v.35 no.1, pp.24-31
    https://doi.org/10.5806/ast.2022.35.1.24
    Mohammed, Ali Fahim (Chemistry Department, College of Science, Babylon University)
    Alshirifi, AN (Chemistry Department, College of Science, Babylon University)
    Kadhim, Kasim Hassan (Chemistry Department, College of Science, Babylon University)

    Abstract

    Herein, we present a simple, precise, accurate, and ultra-sensitive spectrofluorimetric method for estimation of clozapine (CLZ) in tablets and human plasma was developed and then validated. A highly fluorescent brown-yellowish fluorophore was formed (λex=469 nm, λemi=540 nm) as a nucleophilic substitution reaction occurred between CLZ and 4-chloro-7-nitro-2,1,3-benzoxadiazole (NBD-Cl) in alkaline mcllavine buffer (pH 9.0). Optimum values of experimental parameters were carefully determined and optimized. The calibration curve was rectilinear over the concentration range of 80-900 ng mL-1 with a linear correlation coefficient (r=0.9984). The LOD and LOQ were determined to be 14 ng mL-1 and 42 ng mL-1, respectively. The proposed approach has been used successfully to quantification of Clozapine in its commercial formulations and human plasma.

    keywords
    clozapine, NBD-Cl, spectrofluorimetric, human plasma

    상단으로 이동

    분석과학